Back
Seres Therapeutics 10K Form
Sell
43
MCRB
Seres Therapeutics
Last Price:
0.80
Seasonality Move:
-5.38%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MCRB News And Ratings
See the #1 stock for the next 7 days that we like better than MCRB
MCRB Financial Statistics
Sales & Book Value
Annual Sales: | $126.33M |
---|---|
Cash Flow: | $-39.91M |
Price / Cash Flow: | 0 |
Annual Sales: | $-0.57 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -1.18000 |
---|---|
Net Income (TTM): | $-162.11M |
Gross Margin: | $0 |
Return on Equity: | 0% |
Return on Assets: | 0% |
Seres Therapeutics Earnings Forecast
Key Seres Therapeutics Financial Ratios
- The Selling, General & Administrative Expenses for MCRB have been equal to 69.46% of Gross Profit Margin.
- The Research & Development expenses have been 115.46% of Revenue.
- The Interest Expense is -11.59% of Operating Income.
- The Net Earning history of MCRB is -90.02% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 6 years.
Seres Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | MCRB |
CUSIP: | 81750R |
Website: | serestherapeutics.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
MCRB Technical Analysis vs Fundamental Analysis
Sell
43
Seres Therapeutics (MCRB)
is a Sell
Is Seres Therapeutics a Buy or a Sell?
-
Seres Therapeutics stock is rated a Sell
The current Seres Therapeutics [MCRB] share price is $0.80. The Score for MCRB is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.